Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001641172-25-003824

Options or other derivatives

  • Chief Executive Officer returned 13,626 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Meckler Jeffrey A · Chief Executive Officer

Table II: Derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-10 Returned to the company : show line 1 in the form Stock Option (right to buy) −4,750 $0.04 $176 0 D
2025-04-10 Returned to the company : show line 2 in the form Stock Option (right to buy) −3,750 $0.04 $139 0 D
2025-04-10 Returned to the company : show line 3 in the form Stock Option (right to buy) −813 $0.04 $30 0 D
2025-04-10 Returned to the company : show line 4 in the form sStock Option (right to buy) −1,500 $0.04 $56 0 D
2025-04-10 Returned to the company : show line 5 in the form Stock Option (right to buy) −1,563 $0.04 $58 0 D
2025-04-10 Returned to the company : show line 6 in the form Stock Option (right to buy) −1,250 $0.04 $46 0 D
Loading xslF345X05/ownership.xml…